Seoul, South Korea

Hyun-Guy Kang

USPTO Granted Patents = 2 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
2 patents (USPTO):

Title: Innovations in Cancer Treatment by Inventor Hyun-Guy Kang

Introduction

Hyun-Guy Kang is a notable inventor based in Seoul, South Korea, recognized for his significant contributions to cancer treatment through innovative methodologies. With a total of two patents, he has developed techniques that promise to enhance the effectiveness of immunotherapy for cancer patients.

Latest Patents

Hyun-Guy Kang's latest patents revolve around the isolation and proliferation of autologous cancer antigen-specific CD8T cells. His inventions include methods for selecting epitopes recognized by CD8T cells from the autologous cancer antigens present in the blood of individual cancer patients. The processes he developed allow for the effective isolation of these cells by utilizing a peptide corresponding to the selected epitope. Importantly, this approach enables T cells to target and eliminate cancer cells derived from the patients' own bodies, potentially leading to effective treatment options without the severe side effects often associated with traditional therapies.

Career Highlights

Hyun-Guy Kang has worked with esteemed organizations such as the National Cancer Center and Eutilex Co., Ltd. His tenure at these institutions has allowed him to engage with cutting-edge research and development, reinforcing his reputation as a leading figure in the field of cancer immunotherapy.

Collaborations

Throughout his career, Kang has collaborated with notable peers, including Byoung S. Kwon and Kwang-Hui Kim. These partnerships have contributed to the validation and enhancement of his innovative research methodologies.

Conclusion

With his inventions, Hyun-Guy Kang stands at the forefront of transforming cancer treatment through advanced scientific innovation. His methodologies not only contribute to the field of immunotherapy but also pave the way for future developments in the battle against cancer. His work exemplifies how targeted approaches to cancer treatment can lead to promising new therapies that leverage the body's immune system effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…